Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection

Lancet

Volumn 348, Issue 9039, 1996, Pages 1407-1413

  Sgambatti De Andrade, Ana Lucia S ^a   Zicker, Fabio ^b   De Oliveira, Renato Mauricio ^a   Almeida E Silva, Simonne ^a   Luquetti, Alejandro ^a   Travassos, Luiz R ^c   Almeida, Igor C ^c   De Andrade, Soraya S ^a   Guimarães De Andrade, João ^a   Martelli, Celina M T ^a  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^b PAN AMERICAN HEALTH ORGANIZATION   (United States)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BENZNIDAZOLE; INSECTICIDE; NITROIMIDAZOLE DERIVATIVE; PLACEBO; PROTOZOON ANTIBODY;

ANTIBODY TITER; ARTHRALGIA; ARTICLE; BRAZIL; CHAGAS DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; GASTROINTESTINAL TOXICITY; HEADACHE; HEMAGGLUTINATION TEST; HUMAN; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RASH; RURAL AREA; SCHOOL CHILD; SEROCONVERSION; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS; TRYPOMASTIGOTE;

EID: 10544244169     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)04128-1     Document Type: Article

References (30)

1. 1 Zicker F, Smith PG, Almeida Netto JC, Oliveira RM, Zicker EMS. Physical activity, opportunity for reinfection, and sibling history of heart disease as risk factors for Chagas' cardiopathy. Am J Trop Med Hyg 1990; 43: 498-505.
2. 2 Dias JCP. Chagas disease control in Brazil: which strategy after the attack phase? Ann Soc Belg Méd Trop 1991; 71 (suppl 1): 75-86.
3. 3 UNDP/World Bank/ WHO Special Programme for Research and Training in Tropical Diseases. Tropical Disease Research: progress 1975-94: highlights 1993-94: twelfth Programme Report of the UNDP/World bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR). Geneva: WHO, 1995: 125-34.
4. 4 Rassi A, Luquetti A. Therapy of Chagas disease. In: Wendel S, Brener Z, Camargo ME, Rassi A, eds. Chagas disease (American trypanosomiasis): its impact on transfusion and clinical medicine. International Society of Blood Transfusion, Brazil '92, São Paulo, Brazil, 1992: 237-47.
5. 5 Zaidenberg M, Segovia A. Enfermedad de Chagas congenita en la ciudad de Salta, Argentina. Rev Inst Med Trop São Paulo 1993; 35: 35-43.
6. 6 Krettli AV, Cançado JR, Brener Z. Effect of specific chemotherapy on the levels of lytic antibodies in Chagas' disease. Trans R Soc Med Hyg 1982; 76: 334-40.
7. 7 WHO. Control of Chagas disease. WHO Techni Rep Sers no 811, Geneva: WHO, 1991.
8. 8 Smith PG, Morrow RH. Methods for field trials of interventions against tropical diseases: a 'toolbox'. New York: Oxford University Press, 1992.
9. 9 Camargo ME, Silva GR, Castilho EA, Silveira AC. Inquérito sorológico da prevalência de infecção chagásica no Brasil, 1975/1980. Rev Inst Med Trop São Paulo 1984; 26: 192-204.
10. 10 Andrade ALSS, Zicker F, Oliveira RM, et al. Evaluation of risk factors for house infestation by Triatoma infestans in Brazil. Am J Trop Med Hyg 1995; 53: 443-47.
11. 11 Andrade ALSS, Zicker F, Silva IG, Souza JMP, Martelli CMT. Risk factors for Trypanosoma cruzi infection among children in central Brazil: a case-control study in vector control settings. Am J Trop Med Hyg 1995; 92: 183-87.
12. 12 Voller A, Draper C, Bidwell DE, Bartlet A. Microplate enzyme-linked immunosorbent assay for Chagas' disease. Lancet 1975; i: 426-28.
13. 13 Andrade ALSS, Zicker F, Luquetti AO, et al. Surveillance of Trypanosoma cruzi transmission by serological screening of schoolchildren. Bull World Health Organ 1992; 70: 625-29.
14. 14 Almeida IC, Salles NA, Santos MLP, et al. Serum diagnosis of American trypanosomiasis in blood banks: a highly sensitive and specific carbohydrate-rich trypomastigote antigen and why there are so many inconclusive results. Mem Inst Oswaldo Cruz 1995; 90: 72-74.
15. 15 Almeida IC, Ferguson MA, Schenkman S, Travassos LR. Lytic anti-α-galactosyl antibodies from patients with chronic Chagas' disease recognize novel O-linked oligosaccharides on mucin-like glycosyl-phosphatidylinositol-anchored glycoproteins of Trypanosoma cruzi. Biochem J 1994; 304: 793-802.
16. 16 Almeida IC, Rodrigues EG, Travassos LR. Chemiluminescent immunoassays: discrimination between the reactivities of natural and human patient antibodies with antigens from eukaryotic pathogens, Trypanosoma cruzi and Paracoccidioides brasiliensis. J Clin Lab Anal 1994; 8: 424-31.
17. 17 Luquetti AO. Use of Trypanosoma cruzi defined proteins for diagnosis-multicentre trial (+) serological and technical aspects. Mem Inst Oswaldo Cruz 1990; 85: 497-505.
18. 18 Fragata Filho A, Silva MAD, Boainain E. Tratamento etiológico da doença de Chagas nas fases aguda e crônica. Rev Soc Cardiol Estado São Paulo 1994; 4: 192-97.
19. 19 Chiari E. Diagnostic tests for Chagas disease. In: Wendel S, Brener Z, Camargo ME, Rassi A, eds. Chagas disease (American trypanosomiasis): its impact on transfusion and clinical medicine. International Society of Blood Transfusion, Brazil '92, São Paulo, Brazil, 1992: 153-64.
20. 20 Reed GF, Meade BD, Steinhoff MC. The reverse of cumulative distribution plot: a graphic method for exploratory analysis of antibody data. Pediatrics 1995; 96 (suppl): 600-03.
21. 21 Smith PG. Evaluating interventions against tropical diseases. Int J Epidemiol 1987; 16: 159-66.
22. 22 Krettli AU, Cançado R, Brener Z. Criterion of cure of human Chagas' disease after specific chemotherapy: recent advances. Mem Inst Oswaldo Cruz 1984; 79: 157-64.
23. 23 Galvão LMC, Nines RMB, Cançado JR, Brener Z, Krettli AU. Lytic antibody titre as a means of assessing cure after treatment of Chagas disease: a 10 years follow-up study. Trans R Soc Trop Med Hyg 1993; 87: 220-23.
24. 24 Ferreira HO. Tratamento da forma indeterminada da doença de Chagas com Nifurtimox e Benzonidazol. Rev Soc Bras Med Trop 1990; 23: 209-11.
25. 25 Cançado JR, Brener Z. Terapêutica. In: Brener Z, Andrade Z. Trypanosoma cruzi e Doença de Chagas. Rio de Janeiro: Guanabara Koogan, 1979: 362-424.
26. 26 Britto C, Cardoso MA, Monteiro Vanni CM, et al. Polymerase chain reaction detection of Trypanosoma cruzi in human blood samples as a tool for diagnosis and treatment evaluation. Parasitology 1995; 110: 241-47.
27. 27 Almeida IC, Milani SR, Gorin PAJ, Travassos LR. Complement-mediated lysis of Trypanosoma cruzi trypomastigotes by human anti-α-galactosyl antibodies. J Immunol 1991; 146: 2394-400.
28. 28 Cerisola JA, Alvarez M, Rossio AM. Immunodiagnóstico da doença de Chagas evolução serológica de pacientes com doença de Chagas. Rev Inst Med Trop São Paulo 1970; 12: 403-11.
29. 29 Gazinelli RT, Galvão LMC, Krautz G, et al. Use of Trypanosoma cruzi purified glycoprotein (GP57/51) or trypomastigote-shed antigens to assess cure for human Chagas' disease. Am J Trop Med Hyg 1993; 49: 625-35.
30. 30 Andrade SG, Freitas LAR, Payrol S, Pimentel AR, Sadigursky M. Experimental chemotherapy of Trypanosoma cruzi infection: persistence of parasite antigens and positive serology in parasitologically cured mice. Bull World Health Organ 1991; 69: 191-97.